Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa in three female Caucasian patients

被引：0
|
作者：
Antohe, M. [1 ]
Popescu, R. [2 ]
Balaban, M. [1 ]
Calinescu, A. [1 ]
Popescu, C. M. [2 ]
机构：
[1] Colentina Hosp, Dept Dermatol, Bucharest, Romania
[2] Carol Davila Univ Med & Pharm, Colentina Hosp, Dept Dermatol, Bucharest, Romania
来源：
EXPERIMENTAL DERMATOLOGY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P12
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [21] Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination
    Join-Lambert, Olivier
    Ribadeau-Dumas, Florence
    Jullien, Vincent
    Kitzis, Marie-Dominique
    Jais, Jean-Philippe
    Coignard-Biehler, Helene
    Guet-Revillet, Helene
    Consigny, Paul-Henri
    Delage, Maia
    Nassif, Xavier
    Lortholary, Olivier
    Nassif, Aude
    EUROPEAN JOURNAL OF DERMATOLOGY, 2014, 24 (01) : 94 - 95
  • [22] Clindamycin alone may be enough. Is it time to abandon rifampicin for hidradenitis suppurativa?
    Caro, R. D. Caposiena
    Bianchi, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : 1262 - 1262
  • [23] Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa
    Aarts, P.
    van Huijstee, J. C.
    van Der Zee, H. H.
    van Straalen, K. R.
    Prens, E. P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (05) : 904 - 909
  • [24] Reply to: "Comment on 'Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes"'
    Schneller-Pavelescu, Luca
    Vergara-de Caso, Eduardo
    Martorell, Antonio
    Romani, Jorge
    Lazaro, Mireya
    Vilarrasa, Eva
    Diaz-Ley, Blanca
    Vazquez-Osorio, Igor
    Palacios, Juan Manuel Segura
    Azana, Jose Manuel
    Gonzalez-Lopez, Marcos Antonio
    Canueto, Javier
    Molina-Leyva, Alejandro
    Leiva-Salinas, Maria
    Navarro-Trivino, Francisco Jose
    Sanchez-Paya, Jose
    Pascual, Jose C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : E271 - E272
  • [25] Effectiveness of doxycycline and rifampicin combination-therapy in hidradenitis suppurativa: a descriptive prospective study
    Verdaguer Faja, Julia
    Mora-Fernandez, Veronica
    Bassas-Vila, Julio
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 88 - 88
  • [26] Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients
    Bettoli, V.
    Zauli, S.
    Borghi, A.
    Toni, G.
    Minghetti, S.
    Ricci, M.
    Virgili, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (01) : 125 - 126
  • [27] Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampinclindamycin combination
    Olivier Join-Lambert
    Florence Ribadeau-Dumas
    Vincent Jullien
    Marie-Dominique Kitzis
    Jean-Philippe Jais
    Hélène Coignard-Biehler
    Hélène Guet-Revillet
    Paul-Henri Consigny
    Maia Delage
    Xavier Nassif
    Olivier Lortholary
    Aude Nassif
    European Journal of Dermatology, 2014, 24 : 94 - 95
  • [28] Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic
    Albrecht, J.
    Baine, P. A.
    Ladizinski, B.
    Jemec, G. B.
    Bigby, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (04) : 749 - 755
  • [29] Reply to "Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa"
    Martora, Fabrizio
    Potestio, Luca
    Battista, Teresa
    Megna, Matteo
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (08) : e735 - e736
  • [30] Short-term intravenous clindamycin accelerates the benefit of oral clindamycin-rifampicin treatment in hidradenitis suppurativa (HS)
    Kristandt, A.
    Nikolakis, G.
    Hauptmann, M.
    Becker, M.
    Zouboulis, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S159 - S159
12345